Tanaka Kimitaka, Kojima Tetsufumi, Hiraguchi Etsuo, Hashida Hideaki, Noji Takehiro, Hirano Satoshi
1 Department of Surgery, Hakodate Central General Hospital , Hokkaido, Japan .
2 Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine , Hokkaido, Japan .
J Laparoendosc Adv Surg Tech A. 2016 Mar;26(3):180-4. doi: 10.1089/lap.2015.0380. Epub 2016 Feb 9.
It is often difficult to perform percutaneous radiofrequency ablation (RFA) for hepatic tumors beneath the diaphragm. Diaphragmatic thermal damage is one of the fatal late complications of percutaneous transdiaphragmatic RFA. Our experience with laparoscopic transthoracic transdiaphragmatic intraoperative RFA (LTTI-RFA) for hepatic tumors beneath the diaphragm is reported.
Ten patients who underwent LTTI-RFA from 2009 to 2012 were evaluated. Two cases had concomitant partial hepatectomy, and one underwent RFA for two tumors at the same time. The diagnosis was hepatocellular carcinoma in eight cases and metastatic hepatic tumors in two cases. Nine of eleven tumors were located at segments 7 and 8. Nine tumors were less than 20 mm in diameter. The patients were placed in the half left lateral decubitus position with single-lumen tube intubation. After placement of four abdominal ports, a 12-mm port was inserted in the fourth or fifth intercostal space into the diaphragm. The tumor was ablated by an RFA needle through the port. The routine follow-up consisted of laboratory tests and abdominal imaging every 3-6 months.
The median operation time for only one tumor was 137 minutes (range, 105-187 minutes). The median number of times for ablation was three. Severe postoperative complications (>Clavien-Dindo IIIa) were observed in one case (right upper limb paralysis). The median follow-up period was 35 months (range, 11-43 months). There was no local tumor progression. Recurrent hepatic tumor appearance occurred in other parts of the liver in 6 of the 11 patients.
Laparoscopic transthoracic transdiaphragmatic RFA is an acceptable procedure with a low rate of local recurrence.
对位于膈肌下方的肝肿瘤进行经皮射频消融(RFA)通常很困难。膈肌热损伤是经皮经膈肌RFA致命的晚期并发症之一。本文报道了我们使用腹腔镜经胸经膈肌术中RFA(LTTI-RFA)治疗膈肌下方肝肿瘤的经验。
对2009年至2012年接受LTTI-RFA的10例患者进行评估。2例同时行部分肝切除术,1例同时对两个肿瘤进行RFA。诊断为肝细胞癌8例,肝转移瘤2例。11个肿瘤中有9个位于第7和第8段。9个肿瘤直径小于20毫米。患者取左侧半卧位,单腔气管插管。放置4个腹部端口后,在第4或第5肋间间隙插入一个12毫米端口进入膈肌。通过该端口用RFA针消融肿瘤。常规随访包括每3 - 6个月进行实验室检查和腹部影像学检查。
仅对一个肿瘤进行消融的中位手术时间为137分钟(范围105 - 187分钟)。中位消融次数为3次。1例出现严重术后并发症(>Clavien-Dindo IIIa级)(右上肢麻痹)。中位随访期为35个月(范围11 - 43个月)。无局部肿瘤进展。11例患者中有6例在肝脏其他部位出现复发性肝肿瘤。
腹腔镜经胸经膈肌RFA是一种可接受的手术,局部复发率低。